Proceeds from Lines of Credit

Moderna Proceeds from Lines of Credit remained flat by 0.0% to $150.00M in Q4 2025 compared to the prior quarter.

Analysis

StatementCash Flow Statement

SectionFinancing

First reportedQ1 2023

Last reportedQ4 2025Feb 20, 2026

Metric ID: aph_proceeds_from_lines_of_credit

Historical Data

3 years

	FY'23	FY'24	FY'25
Value	$0.00	$0.00	$600.00M

Range$0.00 – $600.00M

Frequently Asked Questions

What is Moderna's proceeds from lines of credit?: Moderna (MRNA) reported proceeds from lines of credit of $150.00M in Q4 2025.